Who owns CORBUS PHARMACEUTICALS HLDGS?
- Ticker: CRBP
- CUSIP Number: 21833p301
Tip: Access positions for across all investors
Analyze quarterly positions in Corbus Pharmaceuticals Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Corbus Pharmaceuticals Hldgs stock
Who bought or sold CORBUS PHARMACEUTICALS HLDGS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cormorant Asset Management | 2.0M | $80M | 100% | Mar 2024 |
|
| Point72 Asset Management | 702k | $28M | 100% | Mar 2024 |
|
| Ikarian Capital | 559k | $22M | 185% | Mar 2024 |
|
| Vanguard Group | 437k | $17M | 144% | Mar 2024 |
|
| Adage Capital Partners GP | 415k | $16M | 100% | Mar 2024 |
|
| Octagon Capital Advisors | 405k | $16M | 100% | Mar 2024 |
|
| Citadel Advisors | 387k | $15M | 100% | Mar 2024 |
|
| Henderson Group | 339k | $13M | 100% | Mar 2024 |
|
| Millennium Management | 325k | $13M | 100% | Mar 2024 |
|
| Assenagon Asset Management | 260k | $10M | 100% | Mar 2024 |
|
| BlackRock | 221k | $8.7M | 172% | Mar 2024 |
|
| T. Rowe Price Associates | 193k | $7.6M | 100% | Mar 2024 |
|
| Barclays | 185k | $7.3M | 100% | Mar 2024 |
|
| Morgan Stanley | 172k | $6.7M | 5129% | Mar 2024 |
|
| Boothbay Fund Management | 156k | $6.1M | 275% | Mar 2024 |
|
| Walleye Trading Advisors | 133k | $5.2M | 100% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 124k | $4.9M | 100% | Mar 2024 |
|
| Geode Capital Management | 109k | $4.3M | 193% | Mar 2024 |
|
| Goldman Sachs Group | 106k | $4.2M | 100% | Mar 2024 |
|
| Prosight Management | 101k | $3.9M | 100% | Mar 2024 |
|
| Susquehanna International | 93k | $3.7M | 164% | Mar 2024 |
|
| Exome Asset Management | 88k | $3.4M | 100% | Mar 2024 |
|
| Ensign Peak Advisors | 68k | $2.6M | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 62k | $2.4M | 11236% | Mar 2024 |
|
| Hudson Bay Capital Management | 43k | $1.7M | 100% | Mar 2024 |
|
| Caption Management | 42k | $1.6M | 100% | Mar 2024 |
|
| Woodline Partners | 41k | $1.6M | 100% | Mar 2024 |
|
| HealthInvest Partners AB | 38k | $1.5M | 100% | Mar 2024 |
|
| Sphera Funds Management | 35k | $1.4M | 100% | Mar 2024 |
|
| Jane Street | 32k | $1.3M | 100% | Mar 2024 |
|
| Bank of America Corporation | 28k | $1.1M | 699775% | Mar 2024 |
|
| Mirae Asset Global Investments | 25k | $976k | 100% | Mar 2024 |
|
| TD Asset Management | 21k | $832k | 100% | Mar 2024 |
|
| Northern Trust | 20k | $784k | 100% | Mar 2024 |
|
| Springbok Capital Management | 18k | $704k | 100% | Mar 2024 |
|
| Man Group | 18k | $694k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 16k | $631k | -4% | Mar 2024 |
|
| ADAR1 Capital Management | 16k | $628k | 100% | Mar 2024 |
|
| UBS Group | 16k | $607k | 4718% | Mar 2024 |
|
| Citigroup | 15k | $601k | 2604% | Mar 2024 |
|
| Squarepoint Ops | 15k | $601k | 100% | Mar 2024 |
|
| Lighthouse Investment Partners | 15k | $586k | 100% | Mar 2024 |
|
| Leucadia National Corporation | 14k | $534k | 100% | Mar 2024 |
|
| Hrt Financial | 12k | $483k | 100% | Mar 2024 |
|
| XTX Topco | 10k | $404k | 100% | Mar 2024 |
|
| Qube Research & Technologies | 9.7k | $379k | 100% | Mar 2024 |
|
| Cambridge Investment Research Advisors | 9.2k | $360k | 100% | Mar 2024 |
|
| FMR | 9.2k | $359k | 173% | Mar 2024 |
|
| UBS O'Connor | 7.5k | $294k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 5.2k | $203k | -77% | Mar 2024 |
|
| Standard Life Aberdeen | 5.1k | $202k | 100% | Mar 2024 |
|
| Cutler | 2.9k | $112k | 100% | Mar 2024 |
|
| Simplex Trading | 2.0k | $78k | 100% | Mar 2024 |
|
| Tower Research Capital | 1.7k | $68k | 100% | Mar 2024 |
|
| JTC Employer Solutions Trustee | 1.1k | $39k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 1.1k | $42k | 3079% | Mar 2024 |
|
| Quarry | 700.00 | $28k | 100% | Mar 2024 |
|
| Group One Trading | 401.00 | $16k | -80% | Mar 2024 |
|
| Carmichael Hill & Associates | 100.00 | $3.9k | 0% | Mar 2024 |
|
| HighMark Wealth Management | 41.00 | $1.6k | 0% | Mar 2024 |
|
| Nbc Securities | 33.00 | $999.999000 | 100% | Mar 2024 |
|
| Advisor Group Holdings | 30.00 | $1.2k | -88% | Mar 2024 |
|
| CWM | 23.00 | $1.0k | 667% | Mar 2024 |
|
| Baystate Wealth Management | 16.00 | $97.000000 | 100% | Dec 2023 |
|
| Fortis Group Advisors | 14.00 | $549.000200 | -50% | Mar 2024 |
|
| Studio Investment Management | 9.00 | $352.999800 | 0% | Mar 2024 |
|
| Goss Wealth Management | 8.00 | $314.000000 | 0% | Mar 2024 |
|
| Scarborough Advisors | 6.00 | $235.000200 | 0% | Mar 2024 |
|
| IFP Advisors | 3.00 | $18.000000 | 0% | Dec 2023 |
|
| BFSG | 1.00 | $40.000000 | -98% | Mar 2024 |
|
| Sandy Spring Bank | 1.00 | $39.000000 | 0% | Mar 2024 |
|
| Atlantic Trust | 1.00 | $38.000000 | 100% | Mar 2024 |
|
| Brian McDonald | 1.00 | $39.000000 | 0% | Mar 2024 |
|
Who sold out of Corbus Pharmaceuticals Hldgs?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sio Capital Management | Sep 2023 | 150k | $1.0M |
| Annapolis Financial Services | Dec 2023 | 23.00 | $139.000500 |
| Keener Financial Planning | Dec 2023 | 6.00 | $0 |